Related Experiment Video
Updated: May 11, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Subacute sclerosing panencephalitis and chronic viral encephalitis
1Department of Pediatric Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Abstract:
Subacute sclerosing panencephalitis (SSPE) is a chronic infection of the central nervous system associated with the presence of mutant measles virus in the brain. It presents as a progressive, usually fatal disease. The diagnosis is based on clinical criteria and an elevated titer of measles antibodies in the cerebrospinal fluid (CSF). Electroencephalography and imaging studies provide supportive laboratory data. A brain biopsy is indicated only when CSF serology is negative or equivocal in a suspected case to assess the presence of inclusion bodies, measles virus antigens, or viral RNA. Among many drugs and methods tried in the treatment, the highest rate of stabilization or improvement was obtained with intraventricular human lymphoblastoid interferon-α and oral inosiplex. Further research for more available and efficient therapeutic regimens is warranted. Measles and SSPE are preventable by maintenance of high rates of immunization in the population.
Insights
Subacute sclerosing panencephalitis (SSPE) is a fatal brain infection caused by mutant measles virus. While intraventricular interferon-α and oral inosiplex show promise, further research is needed for effective treatments.
Area of Science:
- Neuroscience
- Virology
- Immunology
Background:
- Subacute sclerosing panencephalitis (SSPE) is a chronic, progressive, and typically fatal central nervous system infection.
- It is caused by a persistent mutant measles virus within the brain.
- SSPE poses a significant neurological health challenge.
Purpose of the Study:
- To review the diagnostic criteria for SSPE.
- To evaluate the efficacy of various therapeutic interventions.
- To emphasize the importance of measles vaccination for prevention.
Main Methods:
- Diagnosis relies on clinical presentation and elevated measles antibody titers in cerebrospinal fluid (CSF).
- Electroencephalography and neuroimaging provide supportive evidence.
- Brain biopsy is reserved for equivocal CSF serology cases to detect viral markers.
Main Results:
- Intraventricular human lymphoblastoid interferon-α and oral inosiplex demonstrated the highest rates of stabilization or improvement.
- Despite some treatment successes, further research for more accessible and effective therapies is necessary.
- High population immunization rates remain critical for preventing measles and SSPE.
Conclusions:
- SSPE diagnosis is primarily clinical, supported by CSF antibody titers and neuroimaging.
- Current effective treatments are limited, highlighting the need for novel therapeutic strategies.
- Prevention through widespread measles vaccination is the most effective public health measure against SSPE.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Arboviral Encephalitis
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction

